Vitor Abreu de Góes, Postdoctoral Research Fellow at City of Hope, shared a post on LinkedIn:
“Very happy to share our new publication on JCO Journals!
Our group examined the clinical outcomes of rare tumors with ALK alterations treated with targeted therapy.
A special thanks to Dr. Matthew Lee, Dr. Aditya Shreenivas and my mentor Sumanta Pal, MD, FASCO for the guidance and opportunity to collaborate in this work!
Excited to share our new publication in JCO Precision Oncology!
Our group examined clinical outcomes of rare tumors harboring ALK alterations treated with targeted therapy.
Grateful to Dr. Matthew Lee, Dr. Shreenivas, and my mentor Monty Pal for the guidance and opportunity to collaborate on this!”
Title: Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing ALK Alteration Prolongs Treatment Duration
Authors: Vitor Abreu de Góes, Matthew Lee, Miguel Zugman, Ali Moradi, Salvador Jaime-Casas, Koral Shah, Yu Jun Li, Daniela V. Castro, Xiaochen Li, Benjamin Mercier, Joann Hsu, Alexander Chehrazi-Raffle, Vicki Doctor, Amber Moran, Maurie Markman, Aditya Shreenivas, Sumanta Kumar
Other articles featuring Vitor Abreu de Góes on OncoDaily.